165 related articles for article (PubMed ID: 11503323)
1. [Safety of specific cyclo-oxygenase 2 inhibitors].
Verheugt FW
Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1478. PubMed ID: 11503323
[No Abstract] [Full Text] [Related]
2. [Safety of specific cyclo-oxygenase 2 inhibitors].
Knol A
Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1478-9. PubMed ID: 11503324
[No Abstract] [Full Text] [Related]
3. [The use of acetylsalicylic acid in IHD].
Lenkovsky F; Neirinck LG; Glezer SV
Ter Arkh; 1996; 68(8):79-83. PubMed ID: 9019841
[No Abstract] [Full Text] [Related]
4. Efficacy and safety of aspirin in the long-term management of atherothrombosis.
Patrono C
Haematologica; 2002 Jan; 87(1):6-8. PubMed ID: 11801459
[No Abstract] [Full Text] [Related]
5. [Anticoagulant, antiplatelet agents].
Ishikawa K
Nihon Rinsho; 2003 Apr; 61 Suppl 4():647-53. PubMed ID: 12735045
[No Abstract] [Full Text] [Related]
6. Aspirin and its rivals. As your options increase, your choices get harder.
Harv Mens Health Watch; 2002 Dec; 7(5):1-5. PubMed ID: 12499131
[No Abstract] [Full Text] [Related]
7. Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program.
Weir MR; Sperling RS; Reicin A; Gertz BJ
Am Heart J; 2003 Oct; 146(4):591-604. PubMed ID: 14564311
[TBL] [Abstract][Full Text] [Related]
8. Aspirin and the risk of hemorrhagic stroke.
Rosenberg R
J Fam Pract; 1999 Mar; 48(3):169-70. PubMed ID: 10086752
[No Abstract] [Full Text] [Related]
9. Is there less benefit from warfarin in diabetics after myocardial infarction? The numbing complexities of assessing anticoagulant and antiplatelet therapy in the diabetic patient.
Smith DA
Cardiology; 2008; 111(3):158-60. PubMed ID: 18434718
[No Abstract] [Full Text] [Related]
10. [Aspirin. A wonder drug?].
Diez-Ewald M
Invest Clin; 1997 Jun; 38(2):59-61. PubMed ID: 9296640
[No Abstract] [Full Text] [Related]
11. [Long-term therapy with clopidogrel in combination with ASA significantly reduces risk of death, myocardial infarct or stroke].
Minerva Med; 2003 Apr; 94(2):XIII-IV. PubMed ID: 12916522
[No Abstract] [Full Text] [Related]
12. Nonsteroidal anti-Inflammatory drugs and cardiovascular risk.
Howard PA; Delafontaine P
J Am Coll Cardiol; 2004 Feb; 43(4):519-25. PubMed ID: 14975457
[TBL] [Abstract][Full Text] [Related]
13. [ASA therapy or not?].
Strandberg T; Vanhanen H
Duodecim; 2002; 118(6):557-9. PubMed ID: 12232998
[No Abstract] [Full Text] [Related]
14. Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease.
Arjomand H; Cohen M; Ezekowitz MD
J Invasive Cardiol; 2004 May; 16(5):271-8. PubMed ID: 15152137
[TBL] [Abstract][Full Text] [Related]
15. Aspirin for prevention of myocardial infarction.
Mirvis DM
J Tenn Med Assoc; 1995 Oct; 88(10):392-4. PubMed ID: 7475013
[No Abstract] [Full Text] [Related]
16. Aspirin for healthy hearts.
Ornato J
Health News; 2001 Jan; 7(1):6. PubMed ID: 11198412
[No Abstract] [Full Text] [Related]
17. Secondary stroke prevention set to benefit from PRoFESS trial: extended-release dipyridamole plus aspirin (Asasantin Retard) and clopidogrel share very similar benefit-risk ratio in vascular prevention.
Cardiovasc J Afr; 2008; 19(3):165. PubMed ID: 18568182
[No Abstract] [Full Text] [Related]
18. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
[TBL] [Abstract][Full Text] [Related]
19. What price pain relief?
Hochman JS; Shah NR
Circulation; 2006 Jun; 113(25):2868-70. PubMed ID: 16785335
[No Abstract] [Full Text] [Related]
20. Translational therapeutics at the platelet vascular interface. Summary.
FitzGerald GA
Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):s51-2. PubMed ID: 18296588
[No Abstract] [Full Text] [Related]
[Next] [New Search]
